Tesla's Stock Eyes Gains Amid Tariff Policy Shifts

Published 2 days agoTSLA

Tesla's Stock Eyes Gains Amid Tariff Policy Shifts

A significant court ruling has impacted the financial markets by striking down most of former President Donald Trump's widespread tariffs. As reported by Reuters, these changes exclude tariffs on automobiles, steel, and aluminum, but the overall positive sentiment following this ruling contributed to an uptick in major stock indices. This decision reassured investors who had been wary of the economic impacts of protectionist trade policies.

In recent days, Tesla's stock has experienced notable fluctuations. On May 29, 2025, Tesla shares increased by over 2% after CEO Elon Musk announced his decision to distance himself from the Trump administration. This move was perceived positively by investors, who are hopeful that Musk's renewed focus on Tesla could benefit the automaker. However, earlier in the year, on April 2, the company's stock had fallen nearly 4% in premarket trading after reporting lower-than-expected vehicle deliveries for the first quarter, amid concerns about new tariffs.

The introduction of a 25% tariff on foreign-made vehicles and certain auto parts by President Trump earlier in March caused significant drops in automaker shares, with Tesla experiencing a 0.4% decline on March 27, 2025. These developments exemplify how Tesla and similarly positioned companies remain sensitive to the fluctuating landscape of international trade policies, which continue to influence investor confidence and stock performance.

Share this article

Twitter Facebook LinkedIn

Recent Articles

Warner Bros. Discovery Shareholders Reject Executive Pay Hike

Warner Bros. Discovery Shareholders Reject Executive Pay Hike

10 minutes agoWBD

At Warner Bros. Discovery's 2025 annual stockholder meeting, shareholders voted against the proposed executive compensation packages for 2024. The proposal included a 4% increase in CEO David Zaslav's pay, bringing his total to $51.9 million. Over 59% of shareholders expressed their disapproval, highlighting dissatisfaction with the firm's executive pay practices, as reported by Reuters. The rejection of the proposed salary hikes comes amid a challenging period for Warner Bros. Discovery. The company has been struggling with a downturn in its traditional cable TV business, largely due to cord-cutting trends. Despite gaining 5.3 million new streaming subscribers, the company reported a larger-than-expected loss in the first quarter. In response to these challenges, Warner Bros. Discovery is contemplating significant strategic changes. The company is considering breaking up parts of its business, possibly selling or spinning off some of its less successful cable operations. Additionally, it has made a strategic decision to reintroduce the HBO brand to its streaming service Max, aiming to bolster its streaming appeal.

Elon Musk Steps Down from Government Role, Criticizes Fiscal Policy

Elon Musk Steps Down from Government Role, Criticizes Fiscal Policy

25 minutes agoTSLA

Elon Musk has resigned from his position as head of the Department of Government Efficiency (DOGE), a department established by President Trump in January 2025 to modernize government technology and reduce wasteful spending. Musk's resignation comes amid growing frustrations with the fiscal policies of the Trump administration. According to a statement, Musk stepped down on May 30, 2025, dissatisfied with the direction of the department and broader fiscal strategies. Earlier in June 2025, President Trump proposed that Congress rescind $9.4 billion in spending previously approved, much of which was tied to programs endorsed by DOGE. This proposal included budget cuts from various sectors, such as the State Department, USAID, and PEPFAR, with a focus on projects in countries like Venezuela and Zambia. Reuters highlighted these cuts as part of the administration's attempts to rein in government spending. Musk's departure was also marked by his vocal criticism of a tax and spending bill pushed by the Trump administration, describing it as a "disgusting abomination." He argued the bill would significantly increase the national deficit, clashing with fiscal responsibility goals. Meanwhile, concerns were raised regarding potential conflicts of interest, given Musk's roles in both private enterprise and the federal department. Despite this, the White House clarified that Musk served as a senior adviser without direct decision-making authority in governmental operations.

Citigroup Lifts Restrictions on Firearm-Linked Retail Clients

Citigroup Lifts Restrictions on Firearm-Linked Retail Clients

Citigroup is set to reverse its 2018 policy that limited banking services for retail clients engaged in the sale of firearms. This decision reflects a strategic shift in response to changing regulatory landscapes and growing scrutiny over the fair treatment of certain industries. The rollback marks a significant policy change for Citigroup as it aims to address ongoing debates around corporate policies and social causes. Reuters reported that Citigroup’s move comes as a reaction to regulatory adjustments and heightened attention on equitable access to financial services. The company is also updating its employee code of conduct along with its customer financial access policy, emphasizing a non-discriminatory stance regardless of political ties. This aligns with a broader industry trend to enhance transparency and fairness amidst accusations of bias against specific sectors or political ideologies. Citigroup's change in policy arrives amid a politically charged environment, which includes criticisms from figures like former President Donald Trump over corporate involvements in social issues and banking biases related to political orientations. While the bank has discontinued specific restrictions, it holds an optimistic view that communities and lawmakers will continue striving to address gun violence concerns, as reported by the Financial Times.

Moderna to Launch Placebo-Controlled Trial for New COVID-19 Vaccine

Moderna to Launch Placebo-Controlled Trial for New COVID-19 Vaccine

1 hours agoMRNA

On June 3, 2025, U.S. Health and Human Services Secretary Robert F. Kennedy Jr. announced that Moderna will conduct a placebo-controlled trial for its latest COVID-19 vaccine, mNEXSPIKE. This decision comes as part of efforts to address public concerns over the vaccine's safety and efficacy. The trial is designed to enhance transparency and scientific rigor, ensuring robust evaluation of the vaccine. Moderna's mNEXSPIKE, the next-generation COVID-19 vaccine, recently received FDA approval for use in adults aged 65 and older, as well as those aged 12 to 64 with underlying health conditions. Reuters reported that the FDA's oversight will include closely monitoring the trial for any adverse outcomes, aiming to uphold trust in the vaccination program. Previously, Moderna's vaccines have shown a 94.1% efficacy rate in preventing symptomatic COVID-19, with no severe cases among those vaccinated. The decision to enforce a placebo-controlled trial aligns with recent regulatory changes by the FDA, reflecting stricter standards for vaccine approvals. These changes particularly focus on the necessity for comprehensive research, especially for healthy adults under 65. With these developments, the emphasis remains on maintaining high safety and efficacy standards for COVID-19 vaccines through detailed scientific evaluation.